CZ128095A3 - Antimalarial medicament - Google Patents

Antimalarial medicament Download PDF

Info

Publication number
CZ128095A3
CZ128095A3 CZ951280A CZ128095A CZ128095A3 CZ 128095 A3 CZ128095 A3 CZ 128095A3 CZ 951280 A CZ951280 A CZ 951280A CZ 128095 A CZ128095 A CZ 128095A CZ 128095 A3 CZ128095 A3 CZ 128095A3
Authority
CZ
Czechia
Prior art keywords
antimalarial
quinine
medicament
crds
sulfated
Prior art date
Application number
CZ951280A
Other languages
Czech (cs)
English (en)
Inventor
Ivan Havlik
Yutaro Kaneko
Tohru Mimura
Goro Chihara
Original Assignee
Ajinomoto Kk
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ajinomoto Kk filed Critical Ajinomoto Kk
Publication of CZ128095A3 publication Critical patent/CZ128095A3/cs

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/49—Cinchonan derivatives, e.g. quinine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
    • A61K31/727—Heparin; Heparan
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/737—Sulfated polysaccharides, e.g. chondroitin sulfate, dermatan sulfate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A61P33/06—Antimalarials
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Dermatology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
CZ951280A 1993-09-20 1994-09-20 Antimalarial medicament CZ128095A3 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP23329693 1993-09-20

Publications (1)

Publication Number Publication Date
CZ128095A3 true CZ128095A3 (en) 1995-10-18

Family

ID=16952886

Family Applications (1)

Application Number Title Priority Date Filing Date
CZ951280A CZ128095A3 (en) 1993-09-20 1994-09-20 Antimalarial medicament

Country Status (9)

Country Link
US (1) US5780452A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
EP (1) EP0676206B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
JP (1) JP3718849B2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
CA (1) CA2148607A1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
CZ (1) CZ128095A3 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
DE (1) DE69422496T2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
ES (1) ES2142407T3 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
OA (1) OA10157A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
WO (1) WO1995008334A1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1296691B1 (en) 2000-06-30 2005-11-02 Polydex Pharmaceuticals Limited Use of cellulose sulfate and other sulfated polysaccharides to prevent and treat papilloma virus infections
EP1552823A3 (en) * 2000-06-30 2005-09-21 Polydex Pharmaceuticals Limited Cellulose sulfate and other sulfated polysaccharides to prevent and treat papilloma virus infection and other infections
WO2002032905A1 (fr) * 2000-10-20 2002-04-25 Ajinomoto Co.,Inc. Compositions medicamenteuses, dose et procede de traitement du paludisme
FR2998176B1 (fr) 2012-11-16 2015-01-16 Univ Blaise Pascal Clermont Ii Composition de polysaccharide sulfate

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1129148B (de) * 1960-10-19 1962-05-10 Egyt Gyogyszervegyeszeti Gyar Verfahren zur Herstellung von Heparin-Derivaten zytostatisch wirkender Stoffe
GB1227830A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) * 1968-07-18 1971-04-07
US4197643A (en) * 1978-03-14 1980-04-15 University Of Connecticut Orthodontic appliance of titanium alloy
DE3601136A1 (de) * 1986-01-16 1987-07-23 Max Planck Gesellschaft Hemmstoffe der reversen transkriptase fuer prophylaxe und therapie von retrovirus-infektionen in saeugetieren
US4807177A (en) * 1986-06-06 1989-02-21 Ward Richard J Multiple format hand held label printer
US5512672A (en) * 1988-07-07 1996-04-30 Ajinomoto Co., Inc. Curdlan sulfate
JPH0725802B2 (ja) * 1988-11-28 1995-03-22 味の素株式会社 カードランまたはレンチナンの硫酸エステルまたはその塩の製造方法
JPH03218317A (ja) * 1988-12-06 1991-09-25 Japan Found Cancer Res 抗レトロウイルス剤
JP2772813B2 (ja) * 1989-03-03 1998-07-09 サッポロビール株式会社 抗ウイルス作用と免疫賦活作用を有する組成物
SE9003181D0 (sv) * 1990-10-04 1990-10-04 Kabivitrum Ab Use of heparin fraction

Also Published As

Publication number Publication date
US5780452A (en) 1998-07-14
EP0676206A1 (en) 1995-10-11
DE69422496T2 (de) 2002-07-11
EP0676206A4 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1995-10-25
ES2142407T3 (es) 2000-04-16
CA2148607A1 (en) 1995-03-30
OA10157A (en) 1996-12-18
JP3718849B2 (ja) 2005-11-24
DE69422496D1 (de) 2000-02-10
WO1995008334A1 (en) 1995-03-30
EP0676206B1 (en) 2000-01-05

Similar Documents

Publication Publication Date Title
CA1333363C (en) Angiogenesis inhibitor comprising fumagillin
US5219865A (en) Pharmaceutical combination for the prophylaxis and therapy of malaria
JP2702400B2 (ja) 糖尿病性腎症治療用スロデキサイド含有医薬
US4438138A (en) Reduction of cholesterol with meta-chloro α-t-butylaminopropiophenone
WO2020021545A1 (en) Cannabidiol and glucosamine for treating inflammatory joint diseases
EP0362810A1 (en) Antimalarial compositions using quinidine, artemisinine and its derivatives
AU614515B2 (en) A pharmaceutical combination for the prophylaxis and therapy of malaria
RU2730998C2 (ru) Композиции форболовых эфиров и способы их применения для лечения или уменьшения продолжительности цитопении
CZ382799A3 (cs) Použití hyaluronátu zinku proti peptickým vředům
KR101643662B1 (ko) 아포에쿼린 함유 조성물 및 이의 사용 방법
JP2706371B2 (ja) 癌治療用補助剤及びそれを用いたキット
CZ128095A3 (en) Antimalarial medicament
JP3322311B2 (ja) 脳性マラリアに抗する作用を有するアイロプロスト
US20190321325A1 (en) Method for treating multiple sclerosis
WO2005023272A1 (en) Pharmaceutical compositions and methods for lowering blood pressure and pulse rate
JP4580479B2 (ja) 抗ｈｉｖ感染症剤
US6455555B1 (en) Anti-HIV infection agents and method for treating HIV infection
RU2282437C1 (ru) Средство для лечения болезней суставов
CA1307740C (en) Pharmaceutical preparation and method for inhibiting replication of htlv-iii (aids) virus
AU704517B2 (en) Anti-piroplasmotic agent
EP1031351B1 (en) Leishmaniasis remedy containing glucopyranose derivative as the active ingredient
JP2003522792A (ja) 薬剤調製用化合物の用途
JP2022007796A (ja) 新型コロナウイルス感染症予防・治療剤
EP1537866A1 (en) Drug for kidney failure containing oxaluric acid derivative
Hajkowicz et al. Quinine and quinidine